Australia - engelsk - Department of Health (Therapeutic Goods Administration)

ipca pharma (australia) pty ltd - amitriptyline hydrochloride, quantity: 10 mg - tablet - excipient ingredients: colloidal anhydrous silica; hypromellose; lactose monohydrate; magnesium stearate; crospovidone; macrogol 6000; titanium dioxide; maize starch; microcrystalline cellulose; purified talc; brilliant blue fcf aluminium lake - for the treatment of major depression. amitriptyline 50 mg tablets are indicated only for the maintenance treatment of major depression ,nocturnal enuresis where organic pathology has been excluded.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

ipca pharma (australia) pty ltd - amitriptyline hydrochloride, quantity: 25 mg - tablet - excipient ingredients: quinoline yellow aluminium lake; purified talc; colloidal anhydrous silica; macrogol 6000; lactose monohydrate; titanium dioxide; magnesium stearate; microcrystalline cellulose; hypromellose; maize starch; crospovidone - for the treatment of major depression. amitriptyline 50 mg tablets are indicated only for the maintenance treatment of major depression ,nocturnal enuresis where organic pathology has been excluded.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

ipca pharma (australia) pty ltd - amitriptyline hydrochloride, quantity: 50 mg - tablet - excipient ingredients: hypromellose; crospovidone; sunset yellow fcf aluminium lake; maize starch; lactose monohydrate; purified talc; macrogol 6000; magnesium stearate; titanium dioxide; colloidal anhydrous silica; microcrystalline cellulose; indigo carmine aluminium lake - for the treatment of major depression. amitriptyline 50 mg tablets are indicated only for the maintenance treatment of major depression ,nocturnal enuresis where organic pathology has been excluded.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

ipca pharma (australia) pty ltd - amitriptyline hydrochloride, quantity: 10 mg - tablet - excipient ingredients: colloidal anhydrous silica; lactose monohydrate; crospovidone; maize starch; microcrystalline cellulose; titanium dioxide; magnesium stearate; macrogol 6000; purified talc; brilliant blue fcf aluminium lake; hypromellose - for the treatment of major depression. amitriptyline 50 mg tablets are indicated only for the maintenance treatment of major depression ,nocturnal enuresis where organic pathology has been excluded.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - amitriptyline hydrochloride -

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

a menarini australia pty ltd - bilastine, quantity: 20 mg - tablet, uncoated - excipient ingredients: magnesium stearate; sodium starch glycollate type a; colloidal anhydrous silica; microcrystalline cellulose - for the symptomatic treatment of allergic rhinoconjunctivitis (ar - both seasonal allergic rhinitis (sar) and perennial allergic rhinitis (par)) and/or urticaria.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

a menarini australia pty ltd - febuxostat, quantity: 80 mg - tablet - excipient ingredients: microcrystalline cellulose; hyprolose; croscarmellose sodium; magnesium stearate; silicon dioxide; lactose monohydrate; titanium dioxide; purified talc; iron oxide yellow; polyvinyl alcohol; macrogol 3350 - treatment of chronic symptomatic hyperuricaemia in conditions where urate deposition has already occurred (gouty arthritis and/or tophus formation) in adults with gout.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - amitriptyline hydrochloride -

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - amitriptyline hydrochloride -

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - amitriptyline hydrochloride -